-
Mydecine Exports Psilocybin Mushrooms From Jamaica To Canada — An Industry First
Tuesday, March 2, 2021 - 4:46pm | 268Psychedelics and biopharma company Mydecine (CSE: MYCO) (PINK: MYCOF) recently announced the successful export of 20 kilograms of dried psilocybin mushrooms from a cultivation facility in Jamaica to a facility in Canada. A World’s First: According to the Denver-based company, this represents...
-
Psychedelics Companies Look To 'Functional Mushrooms' For Opportunities
Monday, September 21, 2020 - 8:57am | 1684In recent years mushrooms left their dark, hidden habitats to jump into the spotlight of consumer markets. A hunger for natural foods and wellness products propelled consumers to explore the realm of fungi as a source of nutrition and wellness, as well as a means to achieving physical and mental...
-
Mydecine Snags License To Produce, Sell and Export Natural Psilocybin For Research
Wednesday, August 19, 2020 - 2:13pm | 286Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) announced Wednesday that it has begun to exercise its GMP capabilities under a special license to legally produce, transfer, sell, and export pharmaceutical-grade psilocybin. The psilocybin is naturally derived from whole-mushroom extraction...
-
NewLeaf Brands Taps Mydecine Founder To Be COO, Oversee Psychedelics
Monday, May 11, 2020 - 2:00pm | 378Cannabis development company NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) announced Monday it has named Damon Michaels as its new chief operations officer. Michaels sharpened his management skills while working in Ebbu, a Colorado-based cannabis researcher, for over...